BAX mutations have also been detected in the myeloid compartment of CLL patients with clonal hematopoiesis who were treated with VEN [46], which further supports the notion that BAX has a critical role in BH3 mimetic–induced death of myeloid leukemia cells. Here, BAX is linked to B-cell chronic lymphocytic leukemia.